← SynDRA
BETAHISTINE
SynDRA canonical compound SYN0001477 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | HRH1 |
| Mechanism of action | Histamine receptor antagonist |
| Indication | Meniere's disease |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- Histamine receptor agonist
- Histamine receptor antagonist
- HRH3 ANTAGONIST
- Histamine H3 receptor antagonist
- HRH1 AGONIST
- Histamine H1 receptor agonist
- HRH3 INHIBITOR
- HRH3 INVERSE AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- MAOA
- NR1I2
- NPY2R
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- LMNA
- OPRD1
- LCK
- KDM4A
- KCNH2
- IDH1
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HMGCR
- NR3C1
- OPRK1
- GHSR
- SLC47A1
- USP1
- TDP1
- TBXAS1
- TBXA2R
- TARDBP
- TACR2
- TACR1
- TAAR1
Drug classes
- Cardiovascular Agents
- Histamine Agents
- Histamine Agonists
- Neurotransmitter Agents
- Vasodilator Agents
ATC classes
- N07C · ANTIVERTIGO PREPARATIONS
Cross-references
Synonyms
- betahistine dihydrochloride
- betahistine hydrochloride
- betahistine methanesulfonate
- betahistine dihydrobromide
- beta-histine
- betahistine mesilate
- merislon
- betahistine mesylate
- Betahistina
- Histalean
- Vestibo
- N-methyl-2-(pyridin-2-yl)ethanamine
- 2-(2-METHYLAMINOETHYL)PYRIDINE
- Vasomotal
- Serc base
- 2-Pyridineethanamine, N-methyl-
- beta-Histine
- PT 9 base
- Sinmenier (free base)
- methyl[2-(pyridin-2-yl)ethyl]amine
- Betahistinum
- 2-[2-(Methylamino)ethyl]pyridine
- N-Methyl-2-pyridineethylamine
- N-Methyl-2-pyridineethanamine
- Betaistina [DCIT]
- Serc
- Betahistine [INN:BAN]
- 2-(2-(Methylamino)ethyl)pyridine
- N-methyl-2-pyridin-2-ylethanamine
- Betahistinum [INN-Latin]
- Betahistina [INN-Spanish]
- Betaistina
- (2-(2-Pyridyl)ethyl)methylamine
- [2-(2-Pyridyl)ethyl]methylamine
- 2-(beta-Methylaminoethyl)pyridine
- HISTALEAN
- X32KK4201D
- N-Methyl-2-(2-pyridinyl)ethanamine
Look up BETAHISTINE in the interactive SynDRA portal →